Several Wnt/β-catenin antagonists were epigenetically repressed in breast cancer [1], including WIF1 [18], SFRP1 [19], SFRP2 [20], SFRP5 [21], DKK1 [22], and DKK3 [15]. This evidence concerns the gene SFRP2 and breast carcinoma.